National Medical Research Radiological Centre Of The Ministry Of Health Of Russia

This study tests a less intense chemotherapy combination for people with early-stage HER2-positive breast cancer. The goal is to see if a milder regimen (paclitaxel, trastuzumab, and pertuzumab) can clear the cancer before surgery as effectively as the standard stronger regimen, …

This early-stage study tests a new drug made from an enterovirus (EM-I-2024) in 24 adults with advanced solid tumors that cannot be removed by surgery and have not responded to other treatments. The drug is given either through a vein or directly into the artery feeding the tumor…